drugset / Trial / NCT03143192
Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this pilot study is to investigate the safety and efficacy of micropulse (MP) macular laser in combination with intravitreal aflibercept for the treatment of centre-involved diabetic macular edema.
Timeline
- Start
- 2017-03-08
- Primary completion
- 2019-05-09
- Completion
- 2019-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 2 mg | Intravitreal |